Latest Ketones Stories
Data presented from largest combination buprenorphine/naloxone opioid dependence trial ever conducted in the U.S. MORRISTOWN, N.J., Dec. 6, 2014 /PRNewswire/ -- Orexo US, Inc.
Lightlake Therapeutics advances collaboration with NIDA for novel intranasal naloxone application to reverse opioid overdose LONDON, Dec.
Pain Insights, Inc.
WALTHAM, Massachusetts, December 3, 2014 /PRNewswire/ -- EarlySense [http://www.earlysense.com ](R), the market leader in contact free monitoring solutions announced today
MarketReportsOnline.com adds "The US Chronic Pain Market - Focus on Opioids: Trends & Opportunities (2014-2019)" report to its research store. Dallas,
SAN DIEGO, Nov. 25, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the US Patent and Trademark Office granted Arena U.S. Patent No.
CEO to Review Key Achievements During 2014 and Upcoming Milestones for Chronic Pain Pipeline in 2015 NEW YORK, Nov. 24, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc.
- Patent for naltrexone SR formulation expected to extend Contrave protection to 2028 SAN DIEGO, Nov. 21, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc.
STAMFORD, Conn., Nov. 20, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S.
- A political dynamiter.
More Images (1 images) »